Journal of Medical Virology

Papers
(The H4-Index of Journal of Medical Virology is 113. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
The neuroinvasive potential of SARS‐CoV2 may play a role in the respiratory failure of COVID‐19 patients1404
Development and clinical application of a rapid IgM‐IgG combined antibody test for SARS‐CoV‐2 infection diagnosis1082
Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID‐19) implicate special control measures941
The cytokine storm and COVID‐19916
Tocilizumab treatment in COVID‐19: A single center experience913
Postdischarge symptoms and rehabilitation needs in survivors of COVID‐19 infection: A cross‐sectional evaluation896
COVID‐19 patients' clinical characteristics, discharge rate, and fatality rate of meta‐analysis862
Potential interventions for novel coronavirus in China: A systematic review793
Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS‐CoV‐2 infection762
Central nervous system involvement by severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2)698
Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID‐19664
Clinical features and treatment of COVID‐19 patients in northeast Chongqing644
Understanding of COVID‐19 based on current evidence637
The presence of SARS‐CoV‐2 RNA in the feces of COVID‐19 patients609
Omicron variant of SARS‐CoV‐2: Genomics, transmissibility, and responses to current COVID‐19 vaccines541
Coronavirus disease 2019: What we know?515
The impact of COPD and smoking history on the severity of COVID‐19: A systemic review and meta‐analysis476
Stability issues of RT‐PCR testing of SARS‐CoV‐2 for hospitalized patients clinically diagnosed with COVID‐19461
Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS‐CoV‐2458
Predictors of mortality in hospitalized COVID‐19 patients: A systematic review and meta‐analysis426
Clinical characteristics of 3062 COVID‐19 patients: A meta‐analysis406
Elevated interleukin‐6 and severe COVID‐19: A meta‐analysis398
Transmission dynamics of the COVID‐19 outbreak and effectiveness of government interventions: A data‐driven analysis397
Epidemiology of COVID‐19: A systematic review and meta‐analysis of clinical characteristics, risk factors, and outcomes391
Neutrophil‐to‐lymphocyte ratio and lymphocyte‐to‐C‐reactive protein ratio in patients with severe coronavirus disease 2019 (COVID‐19): A meta‐analysis383
Omicron and Delta variant of SARS‐CoV‐2: A comparative computational study of spike protein381
False negative of RT‐PCR and prolonged nucleic acid conversion in COVID‐19: Rather than recurrence377
The establishment of reference sequence for SARS‐CoV‐2 and variation analysis357
C‐reactive protein correlates with computed tomographic findings and predicts severe COVID‐19 early349
Platelet‐to‐lymphocyte ratio is associated with prognosis in patients with coronavirus disease‐19345
Organ‐protective effect of angiotensin‐converting enzyme 2 and its effect on the prognosis of COVID‐19339
In silico studies on the comparative characterization of the interactions of SARS‐CoV‐2 spike glycoprotein with ACE‐2 receptor homologs and human TLRs326
A systematic review of lopinavir therapy for SARS coronavirus and MERS coronavirus—A possible reference for coronavirus disease‐19 treatment option308
Clinical characteristics of hospitalized patients with SARS‐CoV‐2 infection: A single arm meta‐analysis306
The emergence and epidemic characteristics of the highly mutated SARS‐CoV‐2 Omicron variant306
Post‐acute COVID‐19 syndrome (PCS) and health‐related quality of life (HRQoL)—A systematic review and meta‐analysis303
Evolutionary history, potential intermediate animal host, and cross‐species analyses of SARS‐CoV‐2299
Combination of RT‐qPCR testing and clinical features for diagnosis of COVID‐19 facilitates management of SARS‐CoV‐2 outbreak297
COVID‐19 epidemic: Disease characteristics in children293
Development of epitope‐based peptide vaccine against novel coronavirus 2019 (SARS‐COV‐2): Immunoinformatics approach287
Treatment with convalescent plasma for COVID‐19 patients in Wuhan, China286
The clinical characteristics of pneumonia patients coinfected with 2019 novel coronavirus and influenza virus in Wuhan, China282
Proportion of asymptomatic coronavirus disease 2019: A systematic review and meta‐analysis282
Fecal specimen diagnosis 2019 novel coronavirus–infected pneumonia280
Vaccine hesitancy: Beliefs and barriers associated with COVID‐19 vaccination among Egyptian medical students277
The effect of smoking on COVID‐19 severity: A systematic review and meta‐analysis269
Structural variations in human ACE2 may influence its binding with SARS‐CoV‐2 spike protein260
SARS‐CoV‐2 can be detected in urine, blood, anal swabs, and oropharyngeal swabs specimens248
Role of Toll‐like receptors in the pathogenesis of COVID‐19243
The effectiveness of quarantine of Wuhan city against the Corona Virus Disease 2019 (COVID‐19): A well‐mixed SEIR model analysis232
A systematic review and meta‐analysis of children with coronavirus disease 2019 (COVID‐19)226
Novel coronavirus treatment with ribavirin: Groundwork for an evaluation concerning COVID‐19224
Immunoinformatics‐aided identification of T cell and B cell epitopes in the surface glycoprotein of 2019‐nCoV220
Convalescent plasma transfusion for the treatment of COVID‐19: Systematic review219
Imaging and clinical features of patients with 2019 novel coronavirus SARS‐CoV‐2: A systematic review and meta‐analysis213
Potential utilities of mask‐wearing and instant hand hygiene for fighting SARS‐CoV‐2211
Hypoalbuminemia predicts the outcome of COVID‐19 independent of age and co‐morbidity211
Coronavirus disease (COVID‐19) and neonate: What neonatologist need to know208
Elevated level of C‐reactive protein may be an early marker to predict risk for severity of COVID‐19207
Characterization of the novel SARS‐CoV‐2 Omicron (B.1.1.529) variant of concern and its global perspective206
The potential chemical structure of anti‐SARS‐CoV‐2 RNA‐dependent RNA polymerase201
Obesity aggravates COVID‐19: A systematic review and meta‐analysis199
OMICRON (B.1.1.529): A new SARS‐CoV‐2 variant of concern mounting worldwide fear194
Current evidence on efficacy of COVID‐19 booster dose vaccination against the Omicron variant: A systematic review181
Evaluation of sex‐related hormones and semen characteristics in reproductive‐aged male COVID‐19 patients179
A comparison study of SARS‐CoV‐2 IgG antibody between male and female COVID‐19 patients: A possible reason underlying different outcome between sex175
Performance of VivaDiag COVID‐19 IgM/IgG Rapid Test is inadequate for diagnosis of COVID‐19 in acute patients referring to emergency room department171
Analysis of heart injury laboratory parameters in 273 COVID‐19 patients in one hospital in Wuhan, China171
Psychological stress of medical staffs during outbreak of COVID‐19 and adjustment strategy170
Sequence analysis of the emerging SARS‐CoV‐2 variant Omicron in South Africa170
The value of clinical parameters in predicting the severity of COVID‐19169
Tocilizumab for the treatment of severe coronavirus disease 2019168
The transmission and diagnosis of 2019 novel coronavirus infection disease (COVID‐19): A Chinese perspective168
Epidemiological trends and clinical features of the ongoing monkeypox epidemic: A preliminary pooled data analysis and literature review166
Coinfection in SARS‐CoV‐2 infected patients: Where are influenza virus and rhinovirus/enterovirus?165
Relative instantaneous reproduction number of Omicron SARS‐CoV‐2 variant with respect to the Delta variant in Denmark156
Detection profile of SARS‐CoV‐2 using RT‐PCR in different types of clinical specimens: A systematic review and meta‐analysis154
Chronic COVID syndrome: Need for an appropriate medical terminology for long‐COVID and COVID long‐haulers154
Emerging coronaviruses: Genome structure, replication, and pathogenesis151
Evaluation of SARS‐CoV‐2 neutralizing antibodies using a CPE‐based colorimetric live virus micro‐neutralization assay in human serum samples146
Detectable SARS‐CoV‐2 viral RNA in feces of three children during recovery period of COVID‐19 pneumonia145
Omicron variant (B.1.1.529) of SARS‐CoV‐2, a global urgent public health alert!145
Virological and clinical cure in COVID‐19 patients treated with hydroxychloroquine: A systematic review and meta‐analysis140
Prolonged SARS‐CoV‐2 RNA shedding: Not a rare phenomenon140
Clinical characteristics and outcomes of cancer patients with COVID‐19140
SARS‐CoV‐2 ORF9b antagonizes type I and III interferons by targeting multiple components of the RIG‐I/MDA‐5–MAVS, TLR3–TRIF, and cGAS–STING signaling pathways139
Hyperglycemia, hydroxychloroquine, and the COVID‐19 pandemic139
From SARS and MERS CoVs to SARS‐CoV‐2: Moving toward more biased codon usage in viral structural and nonstructural genes139
Should RT‐PCR be considered a gold standard in the diagnosis of COVID‐19?138
Encephalopathy in patients with COVID‐19: A review134
A brief review of influenza virus infection134
Estimation of the basic reproduction number, average incubation time, asymptomatic infection rate, and case fatality rate for COVID‐19: Meta‐analysis and sensitivity analysis134
Omicron variant genome evolution and phylogenetics133
Early phylogenetic estimate of the effective reproduction number of SARS‐CoV‐2132
Characteristics of patients with coronavirus disease (COVID‐19) confirmed using an IgM‐IgG antibody test131
Clinical characteristics of 54 medical staff with COVID‐19: A retrospective study in a single center in Wuhan, China129
Vitamin D insufficiency as a potential culprit in critical COVID‐19 patients126
The epidemiology and clinical characteristics of co‐infection of SARS‐CoV‐2 and influenza viruses in patients during COVID‐19 outbreak125
A large‐scale meta‐analytic atlas of mental health problems prevalence during the COVID‐19 early pandemic125
Analyzing the epidemiological outbreak of COVID‐19: A visual exploratory data analysis approach125
High IL‐6/IFN‐γ ratio could be associated with severe disease in COVID‐19 patients124
Antibodies to coronaviruses are higher in older compared with younger adults and binding antibodies are more sensitive than neutralizing antibodies in identifying coronavirus‐associated illnesses121
Preliminary report on severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) Spike mutation T478K121
Mathematical modeling of interaction between innate and adaptive immune responses in COVID‐19 and implications for viral pathogenesis119
Diagnostic accuracy of an automated chemiluminescent immunoassay for anti‐SARS‐CoV‐2 IgM and IgG antibodies: an Italian experience119
Neutrophil to lymphocyte ratio as prognostic and predictive factor in patients with coronavirus disease 2019: A retrospective cross‐sectional study119
Analysis of 92 deceased patients with COVID‐19118
Emergence of Omicron third lineage BA.3 and its importance118
Impaired glucose metabolism in patients with diabetes, prediabetes, and obesity is associated with severe COVID‐19117
Extrapulmonary complications of COVID‐19: A multisystem disease?116
The anti‐HIV drug nelfinavir mesylate (Viracept) is a potent inhibitor of cell fusion caused by the SARSCoV‐2 spike (S) glycoprotein warranting further evaluation as an antiviral against COVID‐19 infe115
Initial clinical features of suspected coronavirus disease 2019 in two emergency departments outside of Hubei, China113
Conjunctivitis and COVID‐19: A meta‐analysis113
0.044296026229858